Exhaled breath analysis for lung cancer

Journal of Thoracic Disease

Volumn 5, Issue SUPPL.5, 2013, Pages

  Dent, Annette G ^a,b   Sutedja, Tom G ^c   Zimmerman, Paul V ^a,b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Biomarkers; Exhaled breath; Lung cancer; Volatile organic compounds

Indexed keywords

GOLD NANOPARTICLE; VOLATILE ORGANIC COMPOUND;

AGE; BREATH ANALYSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CHEMICAL ANALYZER; CLINICAL INDICATOR; COLORIMETRY; DISEASE SEVERITY; DOG; ELECTRONIC NOSE; EXHALED BREATH ANALYSIS; EXHALED BREATH CONDENSATE; EXPIRED AIR; HUMAN; ION MOBILITY SPECTROMETRY; LUNG CANCER; LUNG FUNCTION; LUNG RESECTION; MASS FRAGMENTOGRAPHY; NANOSENSOR; NONHUMAN; PORTABLE EQUIPMENT; QUARTZ CRYSTAL MICROBALANCE; REVIEW; SEX DIFFERENCE; SMOKING;

EID: 84903186057     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2013.08.44     Document Type: Review

References (61)

1. Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010;19:1893-907.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
4. Buszewski B, Kesy M, Ligor T, et al. Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr 2007;21:553-66.
5. McCulloch M, Jezierski T, Broffman M, et al. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther 2006;5:30-9.
6. Pauling L, Robinson AB, Teranishi R, et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A 1971;68:2374-6.
7. Phillips M. Method for the collection and assay of volatile organic compounds in breath. Anal Biochem 1997;247:272-8.
8. Phillips M, Gleeson K, Hughes JM, et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999;353:1930-3.
9. Mazzone PJ. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Thorac Oncol 2008;3:774-80.
10. Stone BG, Besse TJ, Duane WC, et al. Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men. Lipids 1993;28:705-8.
11. Kneepkens CM, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med 1994;17:127-60.
12. Phillips M, Herrera J, Krishnan S, et al. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl 1999;729:75-88.
13. Phillips M, Cataneo RN, Cummin AR, et al. Detection of lung cancer with volatile markers in the breath. Chest 2003;123:2115-23.
14. Machado RF, Laskowski D, Deffenderfer O, et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 2005;171:1286-91.
15. Poli D, Carbognani P, Corradi M, et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res 2005;6:71.
16. Barker M, Hengst M, Schmid J, et al. Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. Eur Respir J 2006;27:929-36.
17. Dragonieri S, Schot R, Mertens BJ, et al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 2007;120:856-62.
18. Chen X, Xu F, Wang Y, et al. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer 2007;110:835-44.
19. Peng G, Hakim M, Broza YY, et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer 2010;103:542-51.
20. Fuchs P, Loeseken C, Schubert JK, et al. Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer 2010;126:2663-70.
21. Wang Y, Hu Y, Wang D, et al. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Cancer Biomark 2012;11:129-37.
22. Phillips M, Altorki N, Austin JH, et al. Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark 2007;3:95-109.
23. Gordon SM, Szidon JP, Krotoszynski BK, et al. Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem 1985;31:1278-82.
24. Ellis JR, Gleeson FV. Lung cancer screening. Br J Radiol 2001;74:478-85.
25. Bajtarevic A, Ager C, Pienz M, et al. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 2009;9:348.
26. Peled N, Hakim M, Bunn PA Jr, et al. Non-invasive breath analysis of pulmonary nodules. J Thorac Oncol 2012;7:1528-33.
27. Mazzone PJ, Hammel J, Dweik R, et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax 2007;62:565-8.
28. Dragonieri S, Annema JT, Schot R, et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 2009;64:166-70.
29. D'Amico A, Pennazza G, Santonico M. et al. An investigation on electronic nose diagnosis of lung cancer. Lung Cancer 2010;68:170-6.
30. Mazzone PJ, Wang XF, Xu Y, et al. Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J Thorac Oncol 2012;7:137-42.
31. Westhoff M, Litterst P, Freitag L, et al. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 2009;64:744-8.
32. Di Natale C, Macagnano A, Martinelli E, et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron 2003;18:1209-18.
33. Williams H, Pembroke A. Sniffer dogs in the melanoma clinic? Lancet 1989;1:734.
34. Church J, Williams H. Another sniffer dog for the clinic? Lancet 2001;358:930.
35. Willis CM, Church SM, Guest CM, et al. Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ 2004;329:712.
36. Pickel D. Evidence for canine olfactory detection of melanoma. Appl Anim Behav Sci 2004;89:107-16.
37. Horvath G, Jarverud GA, Jarverud S, et al. Human ovarian carcinomas detected by specific odor. Integr Cancer Ther 2008;7:76-80.
38. Horvath G, Andersson H, Paulsson G. Characteristic odour in the blood reveals ovarian carcinoma. BMC Cancer 2010;10:643.
39. Sonoda H, Kohnoe S, Yamazato T, et al. Colorectal cancer screening with odour material by canine scent detection. Gut 2011;60:814-9.
40. Ehmann R, Boedeker E, Friedrich U, et al. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J 2012;39:669-76.
41. Cornu JN, Cancel-Tassin G, Ondet V, et al. Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis. Eur Urol 2011;59:197-201.
42. Buszewski B, Ligor T, Jezierski T, et al. Identification of volatile lung cancer markers by gas chromatography-mass spectrometry: comparison with discrimination by canines. Anal Bioanal Chem 2012;404:141-6.
43. McCulloch M, Turner K, Broffman M. Lung cancer detection by canine scent: will there be a lab in the lab? Eur Respir J 2012;39:511-2.
44. Effros RM, Hoagland KW, Bosbous M, et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 2002;165:663-9.
45. Effros RM, Dunning MB 3rd, Biller J, et al. The promise and perils of exhaled breath condensates. Am J Physiol Lung Cell Mol Physiol 2004;287:L1073-80.
46. Montuschi P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Respir Dis 2007;1:5-23.
47. Grob NM, Aytekin M, Dweik RA. Biomarkers in exhaled breath condensate: a review of collection, processing and analysis. J Breath Res 2008;2:037004.
48. Carpagnano GE, Costantino E, Palladino GP, et al. Microsatellite alterations and cell-free DNA analysis: could they increase the cytology sensitivity in the diagnosis of malignant pleural effusion? Rejuvenation Res 2012;15:265-73.
49. Carpagnano GE, Foschino-Barbaro MP, Mule G, et al. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. Am J Respir Crit Care Med 2005;172:738-44.
50. Carpagnano GE, Foschino-Barbaro MP, Resta O, et al. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer. Oncology 2004;66:180-4.
51. Carpagnano GE, Foschino-Barbaro MP, Spanevello A, et al. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. Am J Respir Crit Care Med 2008;177:337-41.
52. Carpagnano GE, Palladino GP, Martinelli D, et al. Exhaled matrix metalloproteinase-9 in lung cancer. Rejuvenation Res 2012;15:359-65.
53. Carpagnano GE, Spanevello A, Carpagnano F, et al. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients. Lung Cancer 2009;64:334-40.
54. Gessner C, Kuhn H, Toepfer K, et al. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. Lung Cancer 2004;43:215-22.
55. Poli D, Goldoni M, Caglieri A, et al. Breath analysis in non small cell lung cancer patients after surgical tumour resection. Acta Biomed 2008;79 Suppl 1:64-72.
56. Phillips M, Cataneo RN, Greenberg J, et al. Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. J Lab Clin Med 2000;136:243-9.
57. Wehinger A. Lung cancer detection by proton transfer reaction massspectrometric analysis of human breath gas. Int J Mass Spectrom 2007;265:49-59.
58. Lazar Z, Fens N, van der Maten J, et al. Electronic nose breathprints are independent of acute changes in airway caliber in asthma. Sensors (Basel) 2010;10:9127-38.
59. Gordon SM, Wallace LA, Brinkman MC, et al. Volatile organic compounds as breath biomarkers for active and passive smoking. Environ Health Perspect 2002;110:689-98.
60. Phillips M, Altorki N, Austin JH, et al. Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta 2008;393:76-84.
61. Fens N, Zwinderman AH, van der Schee MP, et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2009;180:1076-82.